Antares Pharma $AIS is a current hot run-up stock in biotech. It has both PDUFA date and key phase 3 data from partner BPAX in December. My blog post with notes from 3q2011 conference call: http://www.biotechduediligence.com/1/post/2011/11/antares-pharma-ais-3q2011-earnings-conference-call-notes.html Working on an overhaul of my AIS stock research page, will post link when it's done!